Insider trade

Edwards Lifesciences (EW): Director sold ~$439K

Steven R Loranger, Director at Edwards Lifesciences, sold ~$439K of Edwards Lifesciences shares.

~$439K
Approx. value · 5,739 sh @ $76.42
60K
Holds after · shares reported
Traded
Feb 14, 2025
Filed
Feb 14, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 16, 2024InsiderOfficer sold ~$185K of EW shares in the open market
  2. Jan 16, 2025Insider · 2 peopleInsiders: 2 sales (~$378K)
  3. Feb 13, 2025Insider · 4 peopleInsiders: 5 sales (~$1.8M)
  4. Feb 14, 2025 · this disclosureInsiderDirector sold ~$439K of EW shares in the open market

What came next

  1. Feb 28, 2025Insider · 1 personInsiders: 2 sales (~$796K)
  2. Mar 3, 2025Congress · 1 personMembers of Congress: 2 purchases
  3. Mar 10, 2025Insider · 2 peopleInsiders: 2 sales (~$456K)
  4. Mar 13, 2025InsiderOfficer sold ~$646K of EW shares in the open market
  5. Mar 21, 2025FDAFDA device clearance: FloTrac sensors; FloTrac Jr sensors; Acumen IQ sensors; VolumeView sensors
  6. Mar 26, 2025InsiderCFO sold ~$797K of EW shares in the open market
  7. Mar 27, 2025FDAFDA device clearance: Edwards eSheath Optima introducer set
  8. Apr 7, 2025CongressDisclosed purchase of EW — reported range $15,001 - $50,000
  9. Apr 8, 2025InsiderOfficer sold ~$21K of EW shares in the open market
  10. Apr 8, 2025CongressDisclosed purchase of EW — reported range $1,001 - $15,000
  11. Apr 14, 2025InsiderOfficer sold ~$663K of EW shares in the open market
  12. Apr 21, 2025CongressDisclosed sale of EW — reported range $1,001 - $15,000
  13. May 5, 2025InsiderCEO sold ~$448K of EW shares in the open market
  14. May 7, 2025InsiderOfficer sold ~$20K of EW shares in the open market
  15. May 9, 2025Insider · 2 peopleInsiders: 2 sales (~$862K)
  16. May 14, 2025FDARecall: Brand Name: Optisite Arterial Cannula Product Name: Optisite Arterial Cannula Model/Catalog Number: OPTI16 Software Version: N/A Product Description: Cardiac c…
  17. May 14, 2025FDARecall: Brand Name: FEM-FLEX II Product Name: Femoral Arterial Cannula Model/Catalog Number: FEMII016AS Software Version: N/A Product Description: The Edwards FEMFLEXI…
  18. May 14, 2025FDARecall: Brand Name: FEM-FLEX II Product Name: Femoral Arterial Cannula Model/Catalog Number: FEMII018A Software Version: N/A Product Description: The Edwards FEMFLEXII…
  19. May 14, 2025FDARecall: Brand Name: FEM-FLEX II Product Name: Femoral Arterial Cannula Model/Catalog Number: FEMII016A Software Version: N/A Product Description: The Edwards FEMFLEXII…
  20. May 14, 2025FDARecall: Brand Name: FEM-FLEXII Product Name: Femoral Arterial Cannula Model/Catalog Number: FEMII018AS Software Version: N/A Product Description: The Edwards FEMFLEXII…
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Edwards Lifesciences

For Edwards Lifesciences, OQRO holds 14 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EW page.

How this filing works

Explore the data

Common questions

Which Edwards Lifesciences (EW) insider traded, and how much?

Steven R Loranger, Director at Edwards Lifesciences, sold ~$439K of Edwards Lifesciences shares. 5,739 shares at $76.42.

When did it happen, and when was it made public?

Traded: Feb 14, 2025. Filed: Feb 14, 2025.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Edwards Lifesciences recently?

For Edwards Lifesciences, OQRO holds 14 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the EW page.

Does this mean EW stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Edwards Lifesciences

Everything OQRO holds on this company is on its EW page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data